Skip to main content
Aurobindo Pharma Limited (NSE: AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,537.40
+3.85 (0.25%)
Sep 6, 2024, 3:30 PM IST

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 75.67B INR in the quarter ending June 30, 2024, with 10.46% growth. This brings the company's revenue in the last twelve months to 297.18B, up 16.68% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

Revenue (ttm)
297.18B
Revenue Growth
+16.68%
P/S Ratio
3.03
Revenue / Employee
11.42M
Employees
26,015
Market Cap
892.92B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020230.99B35.35B18.07%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries Limited 9,252.89B
Tata Consultancy Services Limited 2,441.25B
HDFC Bank Limited 2,663.37B
Bharti Airtel Limited 1,510.49B
ICICI Bank Limited 1,686.78B
Infosys Limited 1,555.41B
State Bank of India 3,319.63B
Hindustan Unilever Limited 621.07B
Revenue Rankings

Aurobindo Pharma News

More News